Emcure Pharmaceuticals Limited (NSE:EMCURE)
India flag India · Delayed Price · Currency is INR
1,479.60
+24.70 (1.70%)
Last updated: Aug 14, 2025

Emcure Pharmaceuticals Company Description

Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide.

It offers products in various therapeutic areas, such gynecology, anti-infectives, pain/analgesics, Vitamins, Minerals & Nutrients, blood-related, oncology, respiratory, HIV antivirals, gastro, anti-diabetic, neuro, and cardiovascular.

It provides its products under Orofer XT, Tenectase, Pause, Metpure XL, Vylda, Vitanova, and Proxym brand names.

Emcure Pharmaceuticals Limited was incorporated in 1981 and is based in Pune, India.

Emcure Pharmaceuticals Limited
Country India
Founded 1981
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 6,731
CEO Satish Mehta

Contact Details

Address:
Plot No. P-1 and P-2
Pune, Maharashtra 411057
India
Phone 91 20 3507 0033
Website emcure.com

Stock Details

Ticker Symbol EMCURE
Exchange National Stock Exchange of India
Fiscal Year April - March
Reporting Currency INR
ISIN Number INE168P01015
SIC Code 2834

Key Executives

Name Position
Dr. Sanjay Singh Chief Executive Officer of Gennova Biopharmaceuticals Limited
Satish Ramanlal Mehta Chief Executive Officer, MD and Executive Director
Chetan Rajendra Sharma Company Secretary and Compliance Officer
Naveen Soni Director of Corporate Communications and Public Relations
Vikas Madan Thapar President of Corporate Development, Strategy and Finance
Rajesh Nair President of Human Resources
Sanjay Rajanikant Mehta President of Emerging Markets
Deepak Gondaliya President of Technical Operations
Kuber Mahadeo Jagdale President of API business
R.S. Vasan President of India Business